RxDoctor Payments Data

Jose Saavedra-Belaunde, MD

Urology · San Juan, PRNPI 1851604367

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $36,125 of the $45,194 with a category attached, or 79.9%. Boston Scientific accounts for 77.8% of it on its own, with 15 other manufacturers making up the rest. Among urology clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,194in general payments, 2019–2025

Across 120 payments — averaging $376.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$35K
  • Verity Pharmaceuticals Inc.$5K
  • Procept Biorobotics Corporation$3K
  • Medtronic$298
  • AbbVie$225
  • Johnson & Johnson$203
  • plus $973 from 10 others

What the payments were for

  • Speaking & faculty fees$36,12580%
  • Travel & lodging$2,6716%
  • Food & beverage$6,39814%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,194 in reported general payments places this provider in the 90th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$43,932
Medicare patients
126
Services billed
301

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron57$28,170
Tolterodine Tartrate ErTolterodine Tartrate165$19,359
Tamsulosin Hcl215$3,331
Silodosin27$1,734
Levofloxacin160$1,704
AmantadineAmantadine Hcl36$1,627
Testosterone Cypionate22$1,537
Diclofenac Potassium65$1,309
Alfuzosin Hcl ErAlfuzosin Hcl45$1,070
Trospium Chloride16$924
Bethanechol Chloride18$796
Potassium Citrate ErPotassium Citrate14$768
Cabergoline12$668
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip25$552
Cephalexin29$497

Paid to pharmacies, not to this prescriber.

Other urology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →